This study investigated the impact of genetic variations in CAR (NR1I3) and PXR (NR1I2) genes on variability in plasma EFV exposure and CYP2B6 metabolic activity among TB-HIV co-infected patients on concomitant first-line anti-TB and EFV-based ART in Ethiopia. The gene discussed is NR1I3; the disease is tuberculosis.